AstraZeneca PLC Second quarter and half year results 2012

As expected, generic competition and challenging market conditions reflected in lower second quarter revenues. Progress made on execution of long-term priorities, with the on-market portfolio and the pipeline strengthened through recent business development initiatives. Financial targets for full year unchanged.

Second quarter and half year results 2012

Announced on Thursday 26 July 2012

• Cautionary statement regarding forward looking statements (PDF 59kb)
• Press release (PDF 2078kb)
• Pipeline table (PDF 361kb)

Downloads

• Presentation (PDF 316kb)
• Simon Lowth (Interim Chief Executive Officer) script (PDF 213kb)
• Tony Zook (Executive Vice-President Commercial Operations) script (PDF 234kb)
• Julie Brown (Interim Chief Financial Officer) script (PDF 225kb)

Webcast

Contacts

Media Enquiries

Esra Erkal-Paler +44 20 7604 8030
Sarah Lindgreen +44 20 7604 8033

Investor Enquiries UK

James Ward-Lilley +44 20 7604 8122 mob: +44 7785 432613
Karl Hård +44 20 7604 8123 mob: +44 7789 654364
Nicklas Westerholm +44 20 7604 8124 mob: +44 7585 404950

Investor Enquiries US

Ed Seage +1 302 886 4065 mob: +1 302 373 1361
Jorgen Winroth +1 212 579 0506 mob: +1 917 612 4043